Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

2'-O-Methylation of Ribosomal RNA: Towards an Epitranscriptomic Control of Translation?

Monaco PL, Marcel V, Diaz JJ, Catez F.

Biomolecules. 2018 Oct 3;8(4). pii: E106. doi: 10.3390/biom8040106. Review.

2.

Deletion 6q drives T-cell leukemia progression by ribosome modulation.

Gachet S, El-Chaar T, Avran D, Genescà E, Catez F, Quentin S, Delord M, Thérizols G, Briot D, Meunier G, Hernandez L, Pla M, Smits WK, Buijs-Gladdines JGCAM, Van Loocke W, Menschaert G, André-Schmutz I, Taghon T, Van Vlierberghe P, Meijerink JP, Baruchel A, Dombret H, Clappier E, Diaz JJ, Gazin C, de The H, Sigaux F, Soulier J.

Cancer Discov. 2018 Sep 28. pii: CD-17-0831. doi: 10.1158/2159-8290.CD-17-0831. [Epub ahead of print]

PMID:
30266814
3.

Evidence for rRNA 2'-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes.

Erales J, Marchand V, Panthu B, Gillot S, Belin S, Ghayad SE, Garcia M, Laforêts F, Marcel V, Baudin-Baillieu A, Bertin P, Couté Y, Adrait A, Meyer M, Therizols G, Yusupov M, Namy O, Ohlmann T, Motorin Y, Catez F, Diaz JJ.

Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):12934-12939. doi: 10.1073/pnas.1707674114. Epub 2017 Nov 20.

4.

Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism.

Bash-Imam Z, Thérizols G, Vincent A, Lafôrets F, Polay Espinoza M, Pion N, Macari F, Pannequin J, David A, Saurin JC, Mertani HC, Textoris J, Auboeuf D, Catez F, Dalla Venezia N, Dutertre M, Marcel V, Diaz JJ.

Oncotarget. 2017 Jul 11;8(28):46219-46233. doi: 10.18632/oncotarget.17597.

5.

Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients.

Marcel V, Catez F, Berger CM, Perrial E, Plesa A, Thomas X, Mattei E, Hayette S, Saintigny P, Bouvet P, Diaz JJ, Dumontet C.

PLoS One. 2017 Jan 19;12(1):e0170160. doi: 10.1371/journal.pone.0170160. eCollection 2017.

6.

Ribosome heterogeneity in tumorigenesis: the rRNA point of view.

Marcel V, Catez F, Diaz JJ.

Mol Cell Oncol. 2015 Mar 24;2(3):e983755. doi: 10.4161/23723556.2014.983755. eCollection 2015 Jul-Sep.

7.

p53, a translational regulator: contribution to its tumour-suppressor activity.

Marcel V, Catez F, Diaz JJ.

Oncogene. 2015 Oct 29;34(44):5513-23. doi: 10.1038/onc.2015.25. Epub 2015 Mar 2. Review.

PMID:
25728674
8.
9.

[The ribosome: a new player in tumorigenesis?].

Marcel V, Catez F, Mertani HC, Diaz JJ.

Med Sci (Paris). 2014 Jan;30(1):21-4. doi: 10.1051/medsci/20143001006. Epub 2014 Jan 24. French. No abstract available.

10.

Ribosomes: the future of targeted therapies?

Marcel V, Catez F, Diaz JJ.

Oncotarget. 2013 Oct;4(10):1554-5. No abstract available.

11.

p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer.

Marcel V, Ghayad SE, Belin S, Therizols G, Morel AP, Solano-Gonzàlez E, Vendrell JA, Hacot S, Mertani HC, Albaret MA, Bourdon JC, Jordan L, Thompson A, Tafer Y, Cong R, Bouvet P, Saurin JC, Catez F, Prats AC, Puisieux A, Diaz JJ.

Cancer Cell. 2013 Sep 9;24(3):318-30. doi: 10.1016/j.ccr.2013.08.013.

12.

Centromere architecture breakdown induced by the viral E3 ubiquitin ligase ICP0 protein of herpes simplex virus type 1.

Gross S, Catez F, Masumoto H, Lomonte P.

PLoS One. 2012;7(9):e44227. doi: 10.1371/journal.pone.0044227. Epub 2012 Sep 20.

13.

HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.

Catez F, Picard C, Held K, Gross S, Rousseau A, Theil D, Sawtell N, Labetoulle M, Lomonte P.

PLoS Pathog. 2012;8(8):e1002852. doi: 10.1371/journal.ppat.1002852. Epub 2012 Aug 9.

14.

Binding and interplay of HMG proteins on chromatin: lessons from live cell imaging.

Catez F, Hock R.

Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):15-27. doi: 10.1016/j.bbagrm.2009.11.001. Review.

PMID:
20123065
15.

Activation of ATM depends on chromatin interactions occurring before induction of DNA damage.

Kim YC, Gerlitz G, Furusawa T, Catez F, Nussenzweig A, Oh KS, Kraemer KH, Shiloh Y, Bustin M.

Nat Cell Biol. 2009 Jan;11(1):92-6. doi: 10.1038/ncb1817. Epub 2008 Dec 14.

16.

Delineation of the protein module that anchors HMGN proteins to nucleosomes in the chromatin of living cells.

Ueda T, Catez F, Gerlitz G, Bustin M.

Mol Cell Biol. 2008 May;28(9):2872-83. doi: 10.1128/MCB.02181-07. Epub 2008 Feb 25.

17.

Cell cycle-dependent binding of HMGN proteins to chromatin.

Cherukuri S, Hock R, Ueda T, Catez F, Rochman M, Bustin M.

Mol Biol Cell. 2008 May;19(5):1816-24. doi: 10.1091/mbc.E07-10-1018. Epub 2008 Feb 20.

18.

A novel cell response triggered by interphase centromere structural instability.

Morency E, Sabra M, Catez F, Texier P, Lomonte P.

J Cell Biol. 2007 Jun 4;177(5):757-68.

19.

Determinants of histone H1 mobility and chromatin binding in living cells.

Catez F, Ueda T, Bustin M.

Nat Struct Mol Biol. 2006 Apr;13(4):305-10. Review.

20.

Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes.

Furusawa T, Lim JH, Catez F, Birger Y, Mackem S, Bustin M.

Mol Cell Biol. 2006 Jan;26(2):592-604.

21.

Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1.

Birger Y, Catez F, Furusawa T, Lim JH, Prymakowska-Bosak M, West KL, Postnikov YV, Haines DC, Bustin M.

Cancer Res. 2005 Aug 1;65(15):6711-8.

22.

The dynamics of histone H1 function in chromatin.

Bustin M, Catez F, Lim JH.

Mol Cell. 2005 Mar 4;17(5):617-20. Review.

23.

Chromosomal protein HMGN1 modulates histone H3 phosphorylation.

Lim JH, Catez F, Birger Y, West KL, Prymakowska-Bosak M, Postnikov YV, Bustin M.

Mol Cell. 2004 Aug 27;15(4):573-84.

24.

Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin.

Catez F, Yang H, Tracey KJ, Reeves R, Misteli T, Bustin M.

Mol Cell Biol. 2004 May;24(10):4321-8.

25.

Preparation and functional analysis of HMGN proteins.

Lim JH, Catez F, Birger Y, Postnikov YV, Bustin M.

Methods Enzymol. 2004;375:323-42. No abstract available.

PMID:
14870676
26.

HMGN dynamics and chromatin function.

Catez F, Lim JH, Hock R, Postnikov YV, Bustin M.

Biochem Cell Biol. 2003 Jun;81(3):113-22. Review.

PMID:
12897844
27.

Influence of testosterone on regulation of ODC, antizyme, and N1-SSAT gene expression in mouse kidney.

Levillain O, Greco A, Diaz JJ, Augier R, Didier A, Kindbeiter K, Catez F, Cayre M.

Am J Physiol Renal Physiol. 2003 Sep;285(3):F498-506. Epub 2003 Apr 22.

28.

Mitotic phosphorylation of chromosomal protein HMGN1 inhibits nuclear import and promotes interaction with 14.3.3 proteins.

Prymakowska-Bosak M, Hock R, Catez F, Lim JH, Birger Y, Shirakawa H, Lee K, Bustin M.

Mol Cell Biol. 2002 Oct;22(19):6809-19.

29.

Competition between histone H1 and HMGN proteins for chromatin binding sites.

Catez F, Brown DT, Misteli T, Bustin M.

EMBO Rep. 2002 Aug;3(8):760-6. Epub 2002 Jul 15.

30.

Unique motif for nucleolar retention and nuclear export regulated by phosphorylation.

Catez F, Erard M, Schaerer-Uthurralt N, Kindbeiter K, Madjar JJ, Diaz JJ.

Mol Cell Biol. 2002 Feb;22(4):1126-39.

31.

The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis.

Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL, Youle RJ.

Dev Cell. 2001 Oct;1(4):515-25.

Supplemental Content

Support Center